Shkreli Arrested On Securities Fraud; KaloBios Hit Hard

When FBI agents arrested Turing Pharmaceuticals AG's CEO Martin Shkreli, who also recently was named chief of KaloBios Pharmaceuticals Inc., some had predicted it was a likely outcome after he spiked the price for a toxoplasmosis medicine, Daraprim (pyrimethamine), by more than 5,000% – catching the attention of antitrust investigators in New York and lawmakers on Capitol Hill.